{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T16:12:51Z","timestamp":1791562371330,"version":"4.3.4"},"reference-count":121,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2023,3,22]],"date-time":"2023-03-22T00:00:00Z","timestamp":1679443200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Italian Ministry of Health"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>The Epstein\u2013Barr virus (EBV) is a ubiquitous herpesvirus most often transmitted during infancy and infecting the vast majority of human beings. Usually, EBV infection is nearly asymptomatic and results in life-long persistency of the virus in a latent state under the control of the host immune system. Yet EBV can cause an acute infectious mononucleosis (IM), particularly in adolescents, and is associated with several malignancies and severe diseases that pose a serious threat to individuals with specific inborn error of immunity (IEI). While there is a general consensus on the requirement for functional CD8 T cells to control EBV infection, the role of the natural killer (NK) cells of the innate arm of immunity is more enigmatic. Here we provide an overview of the interaction between EBV and NK cells in the immunocompetent host as well as in the context of primary and secondary immunodeficiencies. Moreover, we report in vitro data on the mechanisms that regulate the capacity of NK cells to recognize and kill EBV-infected cell targets and discuss the potential of recently optimized NK cell-based immunotherapies for the treatment of EBV-associated diseases.<\/jats:p>","DOI":"10.3390\/cancers15061914","type":"journal-article","created":{"date-parts":[[2023,3,23]],"date-time":"2023-03-23T02:35:26Z","timestamp":1679538926000},"page":"1914","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["The Role of NK Cells in EBV Infection and Related Diseases: Current Understanding and Hints for Novel Therapies"],"prefix":"10.3390","volume":"15","author":[{"given":"Maria G.","family":"Desimio","sequence":"first","affiliation":[{"name":"Primary Immunodeficiency Research Unit, Bambino Ges\u00f9 Children\u2019s Hospital, IRCCS, 00165 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela A.","family":"Covino","sequence":"additional","affiliation":[{"name":"Primary Immunodeficiency Research Unit, Bambino Ges\u00f9 Children\u2019s Hospital, IRCCS, 00165 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatrice","family":"Rivalta","sequence":"additional","affiliation":[{"name":"Primary Immunodeficiency Research Unit, Bambino Ges\u00f9 Children\u2019s Hospital, IRCCS, 00165 Rome, Italy"},{"name":"Department of Systems Medicine, University of Rome Tor Vergata, 00133 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caterina","family":"Cancrini","sequence":"additional","affiliation":[{"name":"Primary Immunodeficiency Research Unit, Bambino Ges\u00f9 Children\u2019s Hospital, IRCCS, 00165 Rome, Italy"},{"name":"Department of Systems Medicine, University of Rome Tor Vergata, 00133 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5533-0304","authenticated-orcid":false,"given":"Margherita","family":"Doria","sequence":"additional","affiliation":[{"name":"Primary Immunodeficiency Research Unit, Bambino Ges\u00f9 Children\u2019s Hospital, IRCCS, 00165 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,3,22]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.3389\/fimmu.2018.01869","article-title":"Natural Killer Cells: Development, Maturation, and Clinical Utilization","volume":"9","author":"Abel","year":"2018","journal-title":"Front. Immunol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.jaci.2022.09.022","article-title":"Human Natural Killer Cells: Form, Function, and Development","volume":"151","author":"Mace","year":"2023","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1038\/s41423-019-0206-4","article-title":"Human NK Cells: Surface Receptors, Inhibitory Checkpoints, and Translational Applications","volume":"16","author":"Sivori","year":"2019","journal-title":"Cell. Mol. Immunol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.smim.2014.02.007","article-title":"NK Cell Self Tolerance, Responsiveness and Missing Self Recognition","volume":"26","author":"Shifrin","year":"2014","journal-title":"Semin. Immunol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/0167-5699(90)90097-S","article-title":"In Search of the \u2018Missing Self\u2019: MHC Molecules and NK Cell Recognition","volume":"11","author":"Ljunggren","year":"1990","journal-title":"Immunol. Today"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"408","DOI":"10.3389\/fimmu.2012.00408","article-title":"NKG2D and DNAM-1 Activating Receptors and their Ligands in NK-T Cell Interactions: Role in the NK Cell-Mediated Negative Regulation of T Cell Responses","volume":"3","author":"Zingoni","year":"2013","journal-title":"Front. Immunol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.3389\/fimmu.2019.01812","article-title":"On the Way to Become a Natural Killer Cell","volume":"10","author":"Mikulak","year":"2019","journal-title":"Front. Immunol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.it.2010.08.003","article-title":"CD56 Negative NK Cells: Origin, Function, and Role in Chronic Viral Disease","volume":"31","author":"Ljunggren","year":"2010","journal-title":"Trends Immunol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"102","DOI":"10.3389\/fcimb.2020.00102","article-title":"Memory and Memory-Like NK Cell Responses to Microbial Pathogens","volume":"10","author":"Brillantes","year":"2020","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"208","DOI":"10.3389\/fcimb.2020.00208","article-title":"NK Cell-Mediated Recall Responses: Memory-Like, Adaptive, Or Antigen-Specific?","volume":"10","author":"Stary","year":"2020","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.jaci.2013.07.020","article-title":"Natural Killer Cell Deficiency","volume":"132","author":"Orange","year":"2013","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1111\/imr.12725","article-title":"Emerging Insights into Human Health and NK Cell Biology from the Study of NK Cell Deficiencies","volume":"287","author":"Mace","year":"2019","journal-title":"Immunol. Rev."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1146\/annurev-pathmechdis-012418-013023","article-title":"Epstein-Barr Virus and Cancer","volume":"14","author":"Farrell","year":"2019","journal-title":"Annu. Rev. Pathol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"107fs7","DOI":"10.1126\/scitranslmed.3002878","article-title":"Epstein-Barr Virus: An Important Vaccine Target for Cancer Prevention","volume":"3","author":"Cohen","year":"2011","journal-title":"Sci. Transl. Med."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"713","DOI":"10.3389\/fonc.2019.00713","article-title":"The Global Landscape of EBV-Associated Tumors","volume":"9","author":"Rickinson","year":"2019","journal-title":"Front. Oncol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1038\/s41579-019-0249-7","article-title":"Latency and Lytic Replication in Epstein-Barr Virus-Associated Oncogenesis","volume":"17","year":"2019","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Murata, T., Sugimoto, A., Inagaki, T., Yanagi, Y., Watanabe, T., Sato, Y., and Kimura, H. (2021). Molecular Basis of Epstein-Barr Virus Latency Establishment and Lytic Reactivation. Viruses, 13.","DOI":"10.3390\/v13122344"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.7150\/ijbs.16564","article-title":"Epstein-Barr Virus Lytic Reactivation Regulation and its Pathogenic Role in Carcinogenesis","volume":"12","author":"Li","year":"2016","journal-title":"Int. J. Biol. Sci."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Bu, G., Xie, C., Kang, Y., Zeng, M., and Sun, C. (2022). How EBV Infects: The Tropism and Underlying Molecular Mechanism for Viral Infection. Viruses, 14.","DOI":"10.3390\/v14112372"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.humpath.2018.05.020","article-title":"Epstein-Barr Virus (EBV)-Associated Lymphoid Proliferations, a 2018 Update","volume":"79","author":"Rezk","year":"2018","journal-title":"Hum. Pathol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1084\/jem.187.9.1395","article-title":"Direct Visualization of Antigen-Specific CD8+ T Cells during the Primary Immune Response to Epstein-Barr Virus in Vivo","volume":"187","author":"Callan","year":"1998","journal-title":"J. Exp. Med."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1146\/annurev-immunol-032414-112326","article-title":"The Immunology of Epstein-Barr Virus-Induced Disease","volume":"33","author":"Taylor","year":"2015","journal-title":"Annu. Rev. Immunol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"323","DOI":"10.3389\/fimmu.2016.00323","article-title":"NK Cell Influence on the Outcome of Primary Epstein-Barr Virus Infection","volume":"7","author":"Chijioke","year":"2016","journal-title":"Front. Immunol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.3389\/fimmu.2017.01658","article-title":"Epstein-Barr Virus-Specific Immune Control by Innate Lymphocytes","volume":"8","year":"2017","journal-title":"Front. Immunol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"e33","DOI":"10.1038\/cti.2015.1","article-title":"Infectious Mononucleosis","volume":"4","author":"Balfour","year":"2015","journal-title":"Clin. Transl. Immunol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/bjh.17638","article-title":"Haemophagocytic Lymphohistiocytosis and Epstein-Barr Virus: A Complex Relationship with Diverse Origins, Expression and Outcomes","volume":"196","author":"Curry","year":"2022","journal-title":"Br. J. Haematol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"e28363","DOI":"10.1002\/jmv.28363","article-title":"A Common Mechanism Links Epstein-Barr Virus Infections and Autoimmune Diseases","volume":"95","author":"Zhang","year":"2023","journal-title":"J. Med. Virol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1111\/bjh.14339","article-title":"Severe Epstein-Barr Virus Infection in Primary Immunodeficiency and the Normal Host","volume":"175","author":"Worth","year":"2016","journal-title":"Br. J. Haematol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"15088","DOI":"10.1038\/nrdp.2015.88","article-title":"Post-Transplant Lymphoproliferative Disorders","volume":"2","author":"Dharnidharka","year":"2016","journal-title":"Nat. Rev. Dis. Primers"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1056\/NEJMra1702693","article-title":"Post-Transplantation Lymphoproliferative Disorders in Adults","volume":"378","author":"Dierickx","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1002\/ibd.21582","article-title":"Risk of Malignant Lymphoma in Patients with Inflammatory Bowel Diseases: A Dutch Nationwide Study","volume":"17","author":"Vos","year":"2011","journal-title":"Inflamm. Bowel Dis."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1111\/ejh.12116","article-title":"Methotrexate\/iatrogenic Lymphoproliferative Disorders in Rheumatoid Arthritis: Histology, Epstein-Barr Virus, and Clonality are Important Predictors of Disease Progression and Regression","volume":"91","author":"Ichikawa","year":"2013","journal-title":"Eur. J. Haematol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1182\/blood-2008-09-180315","article-title":"HIV-Associated Lymphomas and Gamma-Herpesviruses","volume":"113","author":"Carbone","year":"2009","journal-title":"Blood"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"756480","DOI":"10.3389\/fonc.2021.756480","article-title":"Modification of EBV-Associated Pathologies and Immune Control by Coinfections","volume":"11","year":"2021","journal-title":"Front. Oncol."},{"key":"ref_35","first-page":"241","article-title":"Primary Immunodeficiencies Associated with EBV Disease","volume":"390","author":"Cohen","year":"2015","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.3389\/fimmu.2018.01103","article-title":"Inherited Immunodeficiencies with High Predisposition to Epstein-Barr Virus-Driven Lymphoproliferative Diseases","volume":"9","author":"Latour","year":"2018","journal-title":"Front. Immunol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1182\/blood.2019000928","article-title":"Primary Immunodeficiencies Reveal the Molecular Requirements for Effective Host Defense Against EBV Infection","volume":"135","author":"Tangye","year":"2020","journal-title":"Blood"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1111\/imr.12791","article-title":"Signaling Pathways Involved in the T-Cell-Mediated Immunity Against Epstein-Barr Virus: Lessons from Genetic Diseases","volume":"291","author":"Latour","year":"2019","journal-title":"Immunol. Rev."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1007\/s00439-020-02145-3","article-title":"Genetic Susceptibility to EBV Infection: Insights from Inborn Errors of Immunity","volume":"139","author":"Tangye","year":"2020","journal-title":"Hum. Genet."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1093\/cid\/ciw160","article-title":"Association of GATA2 Deficiency with Severe Primary Epstein-Barr Virus (EBV) Infection and EBV-Associated Cancers","volume":"63","author":"Cohen","year":"2016","journal-title":"Clin. Infect. Dis."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1172\/JCI61014","article-title":"Partial MCM4 Deficiency in Patients with Growth Retardation, Adrenal Insufficiency, and Natural Killer Cell Deficiency","volume":"122","author":"Gineau","year":"2012","journal-title":"J. Clin. Investig."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"3769","DOI":"10.1172\/JCI64837","article-title":"Human Immunodeficiency-Causing Mutation Defines CD16 in Spontaneous NK Cell Cytotoxicity","volume":"122","author":"Grier","year":"2012","journal-title":"J. Clin. Investig."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"198","DOI":"10.3389\/fimmu.2018.00198","article-title":"Impaired Control of Epstein-Barr Virus Infection in B-Cell Expansion with NF-\u03baB and T-Cell Anergy Disease","volume":"9","author":"Arjunaraja","year":"2018","journal-title":"Front. Immunol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1200\/JCO.2014.56.5101","article-title":"Incidence, Presentation, and Prognosis of Malignancies in Ataxia-Telangiectasia: A Report from the French National Registry of Primary Immune Deficiencies","volume":"33","author":"Suarez","year":"2015","journal-title":"J. Clin. Oncol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"64","DOI":"10.2350\/10-01-0787-CR.1","article-title":"Hodgkin\u2019s and Non-Hodgkin\u2019s Lymphomas Occurring in Two Brothers with Wiskott-Aldrich Syndrome and Review of the Literature","volume":"14","author":"Du","year":"2011","journal-title":"Pediatr. Dev. Pathol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1126\/science.1240094","article-title":"Mg2+ Regulates Cytotoxic Functions of NK and CD8 T Cells in Chronic EBV Infection through NKG2D","volume":"341","author":"Li","year":"2013","journal-title":"Science"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1084\/jem.20160849","article-title":"Combined Immunodeficiency and Epstein-Barr Virus-Induced B Cell Malignancy in Humans with Inherited CD70 Deficiency","volume":"214","author":"Abolhassani","year":"2017","journal-title":"J. Exp. Med."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"14209","DOI":"10.1038\/ncomms14209","article-title":"A Human Immunodeficiency Syndrome Caused by Mutations in CARMIL2","volume":"8","author":"Schober","year":"2017","journal-title":"Nat. Commun."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1007\/s10875-021-01137-w","article-title":"A Double-Blind, Placebo-Controlled, Crossover Study of Magnesium Supplementation in Patients with XMEN Disease","volume":"42","author":"Chauvin","year":"2022","journal-title":"J. Clin. Immunol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1038\/s41590-018-0164-5","article-title":"Comment on: Evidence of Innate Lymphoid Cell Redundancy in Humans","volume":"19","author":"Orange","year":"2018","journal-title":"Nat. Immunol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1038\/s41590-018-0165-4","article-title":"Reply to \u2018Comment on: Evidence of Innate Lymphoid Cell Redundancy in Humans\u2019","volume":"19","author":"Vivier","year":"2018","journal-title":"Nat. Immunol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1038\/ni.3553","article-title":"Evidence of Innate Lymphoid Cell Redundancy in Humans","volume":"17","author":"Barlogis","year":"2016","journal-title":"Nat. Immunol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1016\/j.jaci.2014.07.009","article-title":"Severe Cutaneous Human Papillomavirus Infection Associated with Natural Killer Cell Deficiency Following Stem Cell Transplantation for Severe Combined Immunodeficiency","volume":"134","author":"Kamili","year":"2014","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1182\/blood-2013-07-515528","article-title":"GATA2 Deficiency: A Protean Disorder of Hematopoiesis, Lymphatics, and Immunity","volume":"123","author":"Spinner","year":"2014","journal-title":"Blood"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1182\/blood-2016-08-734236","article-title":"Adaptive NK Cells can Persist in Patients with GATA2 Mutation Depleted of Stem and Progenitor Cells","volume":"129","author":"Schlums","year":"2017","journal-title":"Blood"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1111\/j.1365-2141.2005.05452.x","article-title":"The Immune Response to Primary EBV Infection: A Role for Natural Killer Cells","volume":"129","author":"Williams","year":"2005","journal-title":"Br. J. Haematol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1093\/infdis\/jis646","article-title":"Behavioral, Virologic, and Immunologic Factors Associated with Acquisition and Severity of Primary Epstein-Barr Virus Infection in University Students","volume":"207","author":"Balfour","year":"2013","journal-title":"J. Infect. Dis."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"2533","DOI":"10.1182\/blood-2014-01-553024","article-title":"Role for Early-Differentiated Natural Killer Cells in Infectious Mononucleosis","volume":"124","author":"Azzi","year":"2014","journal-title":"Blood"},{"key":"ref_59","doi-asserted-by":"crossref","unstructured":"B\u00e9ziat, V., Descours, B., Parizot, C., Debr\u00e9, P., and Vieillard, V. (2010). NK Cell Terminal Differentiation: Correlated Stepwise Decrease of NKG2A and Acquisition of KIRs. PLoS ONE, 5.","DOI":"10.1371\/journal.pone.0011966"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"3853","DOI":"10.1182\/blood-2010-04-281675","article-title":"Expression Patterns of NKG2A, KIR, and CD57 Define a Process of CD56dim NK-Cell Differentiation Uncoupled from NK-Cell Education","volume":"116","author":"Riese","year":"2010","journal-title":"Blood"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1016\/j.celrep.2013.11.041","article-title":"Human Natural Killer Cells Prevent Infectious Mononucleosis Features by Targeting Lytic Epstein-Barr Virus Infection","volume":"5","author":"Chijioke","year":"2013","journal-title":"Cell. Rep."},{"key":"ref_62","first-page":"166","article-title":"Dual Role of Natural Killer Cells on Graft Rejection and Control of Cytomegalovirus Infection in Renal Transplantation","volume":"8","author":"Vilches","year":"2017","journal-title":"Front. Immunol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"4492","DOI":"10.4049\/jimmunol.1303211","article-title":"Cutting Edge: NKG2C(Hi)CD57+ NK Cells Respond Specifically to Acute Infection with Cytomegalovirus and Not Epstein-Barr Virus","volume":"192","author":"Hendricks","year":"2014","journal-title":"J. Immunol."},{"key":"ref_64","doi-asserted-by":"crossref","unstructured":"Strowig, T., Brilot, F., Arrey, F., Bougras, G., Thomas, D., Muller, W.A., and M\u00fcnz, C. (2008). Tonsilar NK Cells Restrict B Cell Transformation by the Epstein-Barr Virus Via IFN-Gamma. PLoS Pathog., 4.","DOI":"10.1371\/journal.ppat.0040027"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"4989","DOI":"10.4049\/jimmunol.1301046","article-title":"A Distinct Subpopulation of Human NK Cells Restricts B Cell Transformation by EBV","volume":"191","author":"Vanoaica","year":"2013","journal-title":"J. Immunol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"6130","DOI":"10.18632\/oncotarget.14045","article-title":"Tonsillar CD56brightNKG2A+ NK Cells Restrict Primary Epstein-Barr Virus Infection in B Cells Via IFN-\u03b3","volume":"8","author":"Jud","year":"2017","journal-title":"Oncotarget"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"607","DOI":"10.3389\/fimmu.2016.00607","article-title":"NKG2A-Expressing Natural Killer Cells Dominate the Response to Autologous Lymphoblastoid Cells Infected with Epstein-Barr Virus","volume":"7","author":"Hatton","year":"2016","journal-title":"Front. Immunol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.jcyt.2015.03.611","article-title":"Fully Automated Expansion and Activation of Clinical-Grade Natural Killer Cells for Adoptive Immunotherapy","volume":"17","author":"Granzin","year":"2015","journal-title":"Cytotherapy"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1084\/jem.20161017","article-title":"Two Alternate Strategies for Innate Immunity to Epstein-Barr Virus: One using NK Cells and the Other NK Cells and \u03b3\u03b4 T Cells","volume":"214","author":"Djaoud","year":"2017","journal-title":"J. Exp. Med."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1002\/eji.201141832","article-title":"Decreased NKp46 and NKG2D and Elevated PD-1 are Associated with Altered NK-Cell Function in Pediatric Transplant Patients with PTLD","volume":"42","author":"Wiesmayr","year":"2012","journal-title":"Eur. J. Immunol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"2846","DOI":"10.1111\/ajt.16547","article-title":"Distinct Immunopathological Mechanisms of EBV-Positive and EBV-Negative Posttransplant Lymphoproliferative Disorders","volume":"21","author":"Choquet","year":"2021","journal-title":"Am. J. Transplant."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1182\/bloodadvances.2017015404","article-title":"Poorly Cytotoxic Terminally Differentiated CD56(Neg)CD16(Pos) NK Cells Accumulate in Kenyan Children with Burkitt Lymphomas","volume":"2","author":"Forconi","year":"2018","journal-title":"Blood Adv."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s00262-021-02956-x","article-title":"Reduced Frequency of Cytotoxic CD56(Dim) CD16(+) NK Cells Leads to Impaired Antibody-Dependent Degranulation in EBV-Positive Classical Hodgkin Lymphoma","volume":"71","author":"Kotur","year":"2022","journal-title":"Cancer Immunol. Immunother."},{"key":"ref_74","doi-asserted-by":"crossref","unstructured":"Png, Y.T., Yang, A.Z.Y., Lee, M.Y., Chua, M.J.M., and Lim, C.M. (2021). The Role of NK Cells in EBV Infection and EBV-Associated NPC. Viruses, 13.","DOI":"10.3390\/v13020300"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.4049\/jimmunol.0803218","article-title":"Specific Targeting of the EBV Lytic Phase Protein BNLF2a to the Transporter Associated with Antigen Processing Results in Impairment of HLA Class I-Restricted Antigen Presentation","volume":"182","author":"Horst","year":"2009","journal-title":"J. Immunol."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"2390","DOI":"10.1182\/blood.V90.6.2390","article-title":"Downregulation of TAP1 in B Lymphocytes by Cellular and Epstein-Barr Virus-Encoded Interleukin-10","volume":"90","author":"Zeidler","year":"1997","journal-title":"Blood"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"3366","DOI":"10.1073\/pnas.0611128104","article-title":"Host Shutoff during Productive Epstein-Barr Virus Infection is Mediated by BGLF5 and may Contribute to Immune Evasion","volume":"104","author":"Rowe","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1128\/JVI.01608-10","article-title":"The Epstein-Barr Virus-Encoded BILF1 Protein Modulates Immune Recognition of Endogenously Processed Antigen by Targeting Major Histocompatibility Complex Class I Molecules Trafficking on both the Exocytic and Endocytic Pathways","volume":"85","author":"Zuo","year":"2011","journal-title":"J. Virol."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1128\/JVI.02183-15","article-title":"The Missing Link in Epstein-Barr Virus Immune Evasion: The BDLF3 Gene Induces Ubiquitination and Downregulation of Major Histocompatibility Complex Class I (MHC-I) and MHC-II","volume":"90","author":"Quinn","year":"2015","journal-title":"J. Virol."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1128\/JVI.01777-06","article-title":"The Switch from Latent to Productive Infection in Epstein-Barr Virus-Infected B Cells is Associated with Sensitization to NK Cell Killing","volume":"81","author":"Pappworth","year":"2007","journal-title":"J. Virol."},{"key":"ref_81","doi-asserted-by":"crossref","unstructured":"Wiesner, M., Zentz, C., Mayr, C., Wimmer, R., Hammerschmidt, W., Zeidler, R., and Moosmann, A. (2008). Conditional Immortalization of Human B Cells by CD40 Ligation. PLoS ONE, 3.","DOI":"10.1371\/journal.pone.0001464"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.1038\/bjc.2012.197","article-title":"C-Myc and EBV-LMP1: Two Opposing Regulators of the HLA Class I Antigen Presentation Machinery in Epithelial Cells","volume":"106","author":"Tudor","year":"2012","journal-title":"Br. J. Cancer"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1128\/JVI.01932-15","article-title":"Induction of the Lytic Cycle Sensitizes Epstein-Barr Virus-Infected B Cells to NK Cell Killing that is Counteracted by Virus-Mediated NK Cell Evasion Mechanisms in the Late Lytic Cycle","volume":"90","author":"Williams","year":"2015","journal-title":"J. Virol."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"E6467","DOI":"10.1073\/pnas.1605884113","article-title":"Epstein-Barr Virus microRNAs Reduce Immune Surveillance by Virus-Specific CD8+ T Cells","volume":"113","author":"Albanese","year":"2016","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/tan.13770","article-title":"Epstein-Barr Virus Infections are Strongly Dependent on Activating and Inhibitory KIR-HLA Pairs After T-Cell Replate Unrelated Hematopoietic Stem Cell Transplantation, the Principles, and Method of Pairing Analysis","volume":"94","author":"Nowak","year":"2019","journal-title":"HLA"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1002\/eji.201545757","article-title":"KIR2DL3 and KIR2DL1 show Similar Impact on Licensing of Human NK Cells","volume":"46","author":"Sim","year":"2016","journal-title":"Eur. J. Immunol."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"16981","DOI":"10.1073\/pnas.1304366110","article-title":"Synergistic Inhibition of Natural Killer Cells by the Nonsignaling Molecule CD94","volume":"110","author":"Cheent","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.3389\/fimmu.2018.01415","article-title":"NKG2A Expression is Not Per Se Detrimental for the Anti-Multiple Myeloma Activity of Activated Natural Killer Cells in an in Vitro System Mimicking the Tumor Microenvironment","volume":"9","author":"Mahaweni","year":"2018","journal-title":"Front. Immunol."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.4049\/jimmunol.1102462","article-title":"EBV BILF1 Evolved to Downregulate Cell Surface Display of a Wide Range of HLA Class I Molecules through their Cytoplasmic Tail","volume":"190","author":"Griffin","year":"2013","journal-title":"J. Immunol."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"4375","DOI":"10.4049\/jimmunol.160.9.4375","article-title":"Interaction of HLA-E with Peptides and the Peptide Transporter in Vitro: Implications for its Function in Antigen Presentation","volume":"160","author":"Ulbrecht","year":"1998","journal-title":"J. Immunol."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"19973","DOI":"10.1038\/s41598-020-76344-3","article-title":"Epstein-Barr Virus Peptides Derived from Latent Cycle Proteins Alter NKG2A\u2009+\u2009NK Cell Effector Function","volume":"10","author":"Mbiribindi","year":"2020","journal-title":"Sci. Rep."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1158\/2326-6066.CIR-15-0098","article-title":"NKG2D Receptor and its Ligands in Host Defense","volume":"3","author":"Lanier","year":"2015","journal-title":"Cancer. Immunol. Res."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1093\/intimm\/dxab085","article-title":"DNAM-1 Versus TIGIT: Competitive Roles in Tumor Immunity and Inflammatory Responses","volume":"33","author":"Shibuya","year":"2021","journal-title":"Int. Immunol."},{"key":"ref_94","doi-asserted-by":"crossref","unstructured":"Baugh, R., Khalique, H., and Seymour, L.W. (2020). Convergent Evolution by Cancer and Viruses in Evading the NKG2D Immune Response. Cancers, 12.","DOI":"10.3390\/cancers12123827"},{"key":"ref_95","doi-asserted-by":"crossref","unstructured":"Cifaldi, L., Doria, M., Cotugno, N., Zicari, S., Cancrini, C., Palma, P., and Rossi, P. (2019). DNAM-1 Activating Receptor and its Ligands: How do Viruses Affect the NK Cell-Mediated Immune Surveillance during the various Phases of Infection?. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20153715"},{"key":"ref_96","first-page":"6178","article-title":"Major Histocompatibility Complex Class I-Related Chain A and UL16-Binding Protein Expression on Tumor Cell Lines of Different Histotypes: Analysis of Tumor Susceptibility to NKG2D-Dependent Natural Killer Cell Cytotoxicity","volume":"62","author":"Pende","year":"2002","journal-title":"Cancer Res."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.chom.2009.03.003","article-title":"Diverse Herpesvirus microRNAs Target the Stress-Induced Immune Ligand MICB to Escape Recognition by Natural Killer Cells","volume":"5","author":"Nachmani","year":"2009","journal-title":"Cell. Host Microbe"},{"key":"ref_98","doi-asserted-by":"crossref","unstructured":"Rancan, C., Schirrmann, L., H\u00fcls, C., Zeidler, R., and Moosmann, A. (2015). Latent Membrane Protein LMP2A Impairs Recognition of EBV-Infected Cells by CD8+ T Cells. PLoS Pathog., 11.","DOI":"10.1371\/journal.ppat.1004906"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1182\/blood-2008-12-196287","article-title":"The NKG2D Ligand ULBP4 Binds to TCRgamma9\/delta2 and Induces Cytotoxicity to Tumor Cells through both TCRgammadelta and NKG2D","volume":"114","author":"Kong","year":"2009","journal-title":"Blood"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.cell.2011.12.031","article-title":"Immune Surveillance and Therapy of Lymphomas Driven by Epstein-Barr Virus Protein LMP1 in a Mouse Model","volume":"148","author":"Zhang","year":"2012","journal-title":"Cell"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"5415","DOI":"10.1038\/s41598-020-62081-0","article-title":"Downregulation of HLA-ABC Expression through Promoter Hypermethylation and Downmodulation of MIC-A\/B Surface Expression in LMP2A-Positive Epithelial Carcinoma Cell Lines","volume":"10","author":"Singh","year":"2020","journal-title":"Sci. Rep."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"e02243-21","DOI":"10.1128\/mBio.02243-21","article-title":"The Epstein-Barr Virus Oncogene EBNA1 Suppresses Natural Killer Cell Responses and Apoptosis Early After Infection of Peripheral B Cells","volume":"12","author":"Chakravorty","year":"2021","journal-title":"mBio"},{"key":"ref_103","first-page":"2887","article-title":"Epstein-Barr Virus-Encoded microRNA BART7 Downregulates Major Histocompatibility Complex Class I Chain-Related Peptide A and Reduces the Cytotoxicity of Natural Killer Cells to Nasopharyngeal Carcinoma","volume":"16","author":"Wong","year":"2018","journal-title":"Oncol. Lett."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"508","DOI":"10.3389\/fimmu.2013.00508","article-title":"The DNA Damage Response: A Common Pathway in the Regulation of NKG2D and DNAM-1 Ligand Expression in Normal, Infected, and Cancer Cells","volume":"4","author":"Cerboni","year":"2014","journal-title":"Front. Immunol."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"656","DOI":"10.4049\/jimmunol.1601574","article-title":"Antibody-Dependent NK Cell Activation Differentially Targets EBV-Infected Cells in Lytic Cycle and Bystander B Lymphocytes Bound to Viral Antigen-Containing Particles","volume":"199","author":"Sintes","year":"2017","journal-title":"J. Immunol."},{"key":"ref_106","doi-asserted-by":"crossref","unstructured":"Karsten, C.B., Bartsch, Y.C., Shin, S.A., Slein, M.D., Heller, H.M., Kolandaivelu, K., Middeldorp, J.M., Alter, G., and Julg, B. (2022). Evolution of Functional Antibodies Following Acute Epstein-Barr Virus Infection. PLoS Pathog., 18.","DOI":"10.1371\/journal.ppat.1010738"},{"key":"ref_107","doi-asserted-by":"crossref","unstructured":"Andrei, G., Trompet, E., and Snoeck, R. (2019). Novel Therapeutics for Epstein\u207bBarr Virus. Molecules, 24.","DOI":"10.3390\/molecules24050997"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"104","DOI":"10.3389\/fonc.2019.00104","article-title":"Progress in EBV Vaccines","volume":"9","author":"Mautner","year":"2019","journal-title":"Front. Oncol."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/s41409-019-0548-7","article-title":"Epstein-Barr Virus-Related Post-Transplant Lymphoproliferative Disease (EBV-PTLD) in the Setting of Allogeneic Stem Cell Transplantation: A Comprehensive Review from Pathogenesis to Forthcoming Treatment Modalities","volume":"55","author":"Bazarbachi","year":"2020","journal-title":"Bone Marrow Transpl."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"611","DOI":"10.4143\/crt.2018.191","article-title":"Comparison of Efficacy of Pembrolizumab between Epstein-Barr Virus\u2013Positive and \u2013Negative Relapsed Or Refractory Non-Hodgkin Lymphomas","volume":"51","author":"Kim","year":"2019","journal-title":"Cancer. Res. Treat."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1182\/blood.2019003886","article-title":"Nivolumab Treatment of relapsed\/refractory Epstein-Barr Virus-Associated Hemophagocytic Lymphohistiocytosis in Adults","volume":"135","author":"Liu","year":"2020","journal-title":"Blood"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/s41698-021-00162-7","article-title":"Complete Response to PD-1 Blockade Following EBV-Specific T-Cell Therapy in Metastatic Nasopharyngeal Carcinoma","volume":"5","author":"Smith","year":"2021","journal-title":"NPJ Precis. Oncol."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"3462","DOI":"10.1158\/1078-0432.CCR-13-0855","article-title":"PD-L1 Expression is Characteristic of a Subset of Aggressive B-Cell Lymphomas and Virus-Associated Malignancies","volume":"19","author":"Chen","year":"2013","journal-title":"Clin. Cancer Res."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"556","DOI":"10.3389\/fimmu.2018.00556","article-title":"Adoptive T Cell Therapy for Epstein-Barr Virus Complications in Patients with Primary Immunodeficiency Disorders","volume":"9","author":"McLaughlin","year":"2018","journal-title":"Front. Immunol."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"1079515","DOI":"10.3389\/fimmu.2022.1079515","article-title":"Immunotherapeutic Approaches in EBV-Associated Nasopharyngeal Carcinoma","volume":"13","author":"Li","year":"2023","journal-title":"Front. Immunol."},{"key":"ref_116","doi-asserted-by":"crossref","unstructured":"Lupo, K.B., and Matosevic, S. (2019). Natural Killer Cells as Allogeneic Effectors in Adoptive Cancer Immunotherapy. Cancers (Basel), 11.","DOI":"10.3390\/cancers11060769"},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"732135","DOI":"10.3389\/fimmu.2021.732135","article-title":"Current Perspectives on \u201cOff-the-Shelf\u201d Allogeneic NK and CAR-NK Cell Therapies","volume":"12","author":"Heipertz","year":"2021","journal-title":"Front. Immunol."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/s13045-021-01083-5","article-title":"Chimeric Antigen Receptor Natural Killer (CAR-NK) Cell Design and Engineering for Cancer Therapy","volume":"14","author":"Gong","year":"2021","journal-title":"J. Hematol. Oncol."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1007\/s00262-022-03158-9","article-title":"Phase I Study of Expanded Natural Killer Cells in Combination with Cetuximab for recurrent\/metastatic Nasopharyngeal Carcinoma","volume":"71","author":"Lim","year":"2022","journal-title":"Cancer Immunol. Immunother."},{"key":"ref_120","doi-asserted-by":"crossref","unstructured":"Yiu, S.P.T., Dorothea, M., Hui, K.F., and Chiang, A.K.S. (2020). Lytic Induction Therapy Against Epstein-Barr Virus-Associated Malignancies: Past, Present, and Future. Cancers, 12.","DOI":"10.3390\/cancers12082142"},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1016\/j.molmed.2017.10.002","article-title":"Boosting Natural Killer Cell-Based Immunotherapy with Anticancer Drugs: A Perspective","volume":"23","author":"Cifaldi","year":"2017","journal-title":"Trends Mol. Med."}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/15\/6\/1914\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T19:00:51Z","timestamp":1760122851000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/15\/6\/1914"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,22]]},"references-count":121,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2023,3]]}},"alternative-id":["cancers15061914"],"URL":"https:\/\/doi.org\/10.3390\/cancers15061914","relation":{},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,22]]}}}